Contraindications to Amiodarone
Amiodarone is absolutely contraindicated in patients with cardiogenic shock, marked sinus bradycardia, and second- or third-degree AV block without a functioning pacemaker, as well as in those with known hypersensitivity to amiodarone or iodine. 1
Absolute Contraindications
The following conditions represent absolute contraindications where amiodarone must not be used:
- Cardiogenic shock 1
- Marked sinus bradycardia 1
- Second- or third-degree AV block without a functioning pacemaker 2, 1
- Known hypersensitivity to amiodarone, its components, or iodine 1
- Severe sinus node dysfunction 3
- Heart transplant patients 3
Critical Relative Contraindications
These conditions require extreme caution and often represent practical contraindications in most clinical scenarios:
Cardiovascular Conditions
- Pre-excitation syndromes (e.g., WPW) with atrial fibrillation - IV amiodarone may increase ventricular response and precipitate ventricular fibrillation 3
- Bradycardia (heart rate <60 bpm) - particularly concerning as amiodarone causes bradycardia in 1-3% of patients 3
- Hypotension (systolic BP <100 mmHg) - IV amiodarone causes hypotension in 16% of patients 3
- Moderate to severe left ventricular failure - requires careful assessment 3
Pulmonary Conditions
- Pre-existing inflammatory lung disease - significantly increases risk of potentially fatal pulmonary toxicity 3
- Severe chronic obstructive pulmonary disease 3
- History of asthma 3
Hepatic and Metabolic Conditions
- Severe hepatic dysfunction - amiodarone causes hepatotoxicity at 0.6% annually; discontinue if liver enzymes exceed 3x normal 2, 3
- Hyperthyroidism - amiodarone contains significant iodine and can worsen thyroid dysfunction 3
Other High-Risk Conditions
Special Population Considerations
Pregnancy
- Avoid in pregnancy, especially first trimester - risk of congenital malformations 3
Patients on Specific Medications
Amiodarone should not be used without expert consultation in patients taking:
- Procainamide or other QT-prolonging medications 3
- Dronedarone - contraindicated in permanent atrial fibrillation due to increased stroke, MI, and cardiovascular death risk 3
Drug Interaction Warnings Requiring Dose Adjustments
When amiodarone must be used with these medications, mandatory dose reductions are required:
- Warfarin: reduce dose by 50% and monitor INR at least weekly for first 6 weeks 3
- Digoxin: reduce dose by 50% due to significant elevation of digoxin levels 3, 4
- Statins: use with extreme caution due to increased myopathy/rhabdomyolysis risk 3
Mandatory Pre-Treatment Assessment
Before initiating amiodarone, the following baseline evaluations are required to identify contraindications 2, 3:
- Complete history focusing on congestive heart failure, arrhythmia symptoms, and concomitant medications
- Chest radiograph - to establish baseline for pulmonary toxicity monitoring
- Thyroid studies (TSH, free T4) - to identify pre-existing thyroid dysfunction
- Liver transaminase levels - to establish baseline hepatic function
- Pulmonary function tests including DLCO - critical for detecting early pulmonary toxicity
- ECG - to document baseline QT interval and conduction abnormalities
- Ophthalmologic examination - if pre-existing visual impairment present
- Digoxin level, PT/INR - when applicable
Common Pitfalls to Avoid
- Do not overlook subclinical sinus node dysfunction - amiodarone will unmask and worsen this condition 3
- Do not assume QT prolongation alone is a contraindication - while amiodarone prolongs QT in nearly all patients, torsades de pointes is rare (<1% annually) compared to other antiarrhythmics 2, 3
- Do not use in patients with uncorrected hypokalemia or hypomagnesemia - these electrolyte abnormalities significantly increase proarrhythmic risk 3
- Do not initiate without establishing a monitoring plan - pulmonary toxicity can develop rapidly without antecedent abnormalities 2